» Articles » PMID: 30299488

Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury

Abstract

Background: Radiation-induced brain injury is a nonnegligible issue in the management of cancer patients treated by partial or whole brain irradiation. In particular, temporal lobe injury (TLI), a deleterious late complication in nasopharyngeal carcinoma, greatly affects the long-term life quality of these patients. Although genome-wide association studies (GWASs) have successfully identified single nucleotide polymorphisms (SNPs) associated with radiation toxicity, genetic variants contributing to the radiation-induced brain injury have not yet been assessed.

Methods: We recruited and performed follow-up for a prospective observational cohort, Genetic Architecture of Radiotherapy Toxicity and Prognosis, using magnetic resonance imaging for TLI diagnosis. We conducted genome-wide association analysis in 1082 patients and validated the top associations in two independent cohorts of 1119 and 741 patients, respectively. All statistical tests were two-sided.

Results: We identified a promoter variant rs17111237 (A > G, minor allele frequency [MAF] = 0.14) in CEP128 associated with TLI risk (hazard ratio = 1.45, 95% confidence interval = 1.26 to 1.66, Pcombined=3.18 × 10-7) which is in moderate linkage disequilibrium (LD) with rs162171 (MAF = 0.18, R2 = 0.69), the top signal in CEP128 (hazard ratio = 1.46, 95% confidence interval = 1.29-1.66, Pcombined= 6.17 × 10-9). Combining the clinical variables with the top SNP, we divided the patients into different subgroups with varying risk with 5-year TLI-free rates ranging from 33.7% to 95.5%. CEP128, a key component of mother centriole, tightly interacts with multiple radiation-resistant genes and plays an important role in maintaining the functional cilia, which otherwise will lead to a malfunction of the neural network. We found that A > G alteration at rs17111237 impaired the promoter activity of CEP128 and knockdown of CEP128 decreased the clonogenic cell survival of U87 cells under radiation. Noteworthy, 12.7% (27/212) of the GWAS-based associated genes (P < .001) were enriched in the neurogenesis pathway.

Conclusions: This three-stage study is the first GWAS of radiation-induced brain injury that implicates the genetic susceptibility gene CEP128 involved in TLI development and provides the novel insight into the underlying mechanisms of radiation-induced brain injury.

Citing Articles

Radiation-Induced Brain Injury: Mechanistic Insights and the Promise of Gut-Brain Axis Therapies.

Li M, Tong F, Wu B, Dong X Brain Sci. 2025; 14(12.

PMID: 39766494 PMC: 11674909. DOI: 10.3390/brainsci14121295.


Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.

Jin J, Guo S, Liu L, Wen D, Liu R, Lin J BMC Cancer. 2024; 24(1):1223.

PMID: 39358733 PMC: 11447939. DOI: 10.1186/s12885-024-12966-4.


Precision based approach to tailoring radiotherapy in the multidisciplinary management of pediatric central nervous system tumors.

Phuong C, Qiu B, Mueller S, Braunstein S J Natl Cancer Cent. 2024; 3(2):141-149.

PMID: 39035723 PMC: 11256719. DOI: 10.1016/j.jncc.2023.03.001.


Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: a large cohort retrospective study.

Hou J, He Y, Li H, Ai Z, Lu Q, Zeng B Radiat Oncol. 2024; 19(1):9.

PMID: 38243277 PMC: 10797916. DOI: 10.1186/s13014-024-02400-1.


Deep learning-based precise prediction and early detection of radiation-induced temporal lobe injury for nasopharyngeal carcinoma.

OuYang P, Zhang B, Guo J, Liu J, Li J, Peng Q EClinicalMedicine. 2023; 58:101930.

PMID: 37090437 PMC: 10114519. DOI: 10.1016/j.eclinm.2023.101930.


References
1.
Andersen P, Borch-Johnsen K, Deckert T, Green A, Hougaard P, Keiding N . A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics. 1985; 41(4):921-32. View

2.
Guemez-Gamboa A, Coufal N, Gleeson J . Primary cilia in the developing and mature brain. Neuron. 2014; 82(3):511-21. PMC: 4104280. DOI: 10.1016/j.neuron.2014.04.024. View

3.
Kerns S, De Ruysscher D, Andreassen C, Azria D, Barnett G, Chang-Claude J . STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother Oncol. 2013; 110(1):182-8. PMC: 4786020. DOI: 10.1016/j.radonc.2013.07.011. View

4.
Barnett G, Thompson D, Fachal L, Kerns S, Talbot C, Elliott R . A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiother Oncol. 2014; 111(2):178-85. DOI: 10.1016/j.radonc.2014.02.012. View

5.
Stone J, DeAngelis L . Cancer-treatment-induced neurotoxicity--focus on newer treatments. Nat Rev Clin Oncol. 2015; 13(2):92-105. PMC: 4979320. DOI: 10.1038/nrclinonc.2015.152. View